Katherine Groff

Increasing the use of animal-free recombinant antibodies.

W. Casey, D. Allen, A. Clippinger, 2020, ALTEX.

Review of Evidence of Environmental Impacts of Animal Research and Testing

T. Capaldo, Eric Bachli, Katherine Groff, 2014 .

Governance for Conservation Risks and Crime

Katherine Groff, Mark Axelrod, J. Colwell, 2017 .

Modern affinity reagents: Recombinant antibodies and aptamers.

A. Clippinger, Jeffrey Brown, Katherine Groff, 2015, Biotechnology advances.

Itching for change: Embracing modern flea and tick product development.

Patricia L Bishop, Katherine Groff, 2017, Regulatory toxicology and pharmacology : RTP.

In Vitro and Integrated In Vivo Strategies to Reduce Animal Use in Genotoxicity Testing.

S. Doak, R. Corvi, S. Pfuhler, 2021, Mutagenesis.

Maximizing the relevance and reproducibility of A549 cell culture using FBS-free media.

A. Gutleb, S. Cambier, A. Stucki, 2022, Toxicology in vitro : an international journal published in association with BIBRA.

Animal metrics: Tracking contributions of new approach methods to reduced animal use.

M. S. Marty, A. Andrus, Katherine Groff, 2021, ALTEX.

An approach to identifying quality research antibodies.

W. Casey, D. Allen, A. Clippinger, 2022, BioTechniques.